Indian Government Ends Bayer’s Monopoly on Cancer Drug

The Indian government will allow a local company to manufacture a generic version of the cancer drug Nexevar, which is currently patented by Bayer. A Common Dreams post explained that the the government’s ruling is based on a trade law that gives the government power to allow the manufacturing of generic versions of otherwise unaffordable drugs. It enables Natco Pharma to create a version of Nexevar that will cost $176 for 120 tablets. Bayer was charging about $5,600 for the same amount. Bayer spokeswoman Sabina Cusimano told the Associated Press, “We will see if we can further defend our intellectual property rights in India.”

October 27, 2016 NRA Top Trump Funder National Rifle Association committees making independent campaign expenditures to oppose Democratic presidential nominee Hillary Clinton have spent more than $14 million on the race, surpassing the spending of the most active pro-Trump Super PAC. Acc... Read More >